Evidence map›Paper›PMID 41728264›Full record

ArticleBrain communications2026

Anatomical phenotyping and staging of brain arteriovenous malformations.

Benjamin Beyersdorf, Yannis Schwieger, Luis Padevit, Zsolt Kulcsar, Menno R Germans, Luca Regli, Kevin Akeret

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Benjamin BeyersdorfDepartment of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.
Yannis SchwiegerDepartment of Surgery, Stadtspital Triemli, 8063 Zurich, Switzerland.
Luis PadevitDepartment of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.
Zsolt KulcsarDepartment of Neuroradiology, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.
Menno R GermansDepartment of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.
Luca RegliDepartment of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.ORCID https://orcid.org/0000-0003-4639-4474
Kevin AkeretDepartment of Neurosurgery, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, 8091 Zurich, Switzerland.ORCID https://orcid.org/0000-0002-5946-4999

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain arteriovenous malformations (AVMs) are potentially life-threatening vascular anomalies that pose significant clinical challenges due to their heterogeneous anatomy and unpredictable natural history. Existing risk stratification models largely rely on isolated imaging markers and fail to account for the dynamic spatial-temporal complexity of AVMs. Building on our prior work, demonstrating how ontogenesis dictates clinical outcomes of neuroepithelial tumours, we hypothesize that AVMs are similarly influenced by developmental processes that define their spatial distribution, vascular architecture and susceptibility to complications. Here, we present the protocol and pilot data of our multicentre, retrospective and prospective observational study, which introduces a multidimensional approach integrating precise anatomical phenotyping with ontogenetic mapping and the analysis of dynamic structural changes over time. By leveraging unsupervised non-negative matrix factorization, we identified six biologically plausible meta-topologies in our single-centre pilot dataset of 416 patients, supporting the feasibility of this approach. We now seek to expand the study into a multicentre effort with both retrospective and prospective enrollment, aiming for a total sample size of ∼1000 patients. This expansion is essential to enhance the granularity, reproducibility and clinical utility of the meta-topologies. Ultimately, the objective of this integrative framework is to facilitate the development of a robust biologically informed risk-stratifying staging system, enhancing personalized treatment strategies and optimizing patient outcomes.

Indexed as

AVMhaemorrhagemeta-topologyontogenesisrisk stratification

Identifiers

PMID41728264
PMCPMC12917541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.